rivaroxaban

Interview

10/30/2023

R. Kevin Rogers, MD, MSc, RPVI

University of Colorado School of Medicine, Aurora, Colorado

R. Kevin Rogers, MD, MSc, RPVI Unive...

Dr. Rogers provides insight into the barriers that may be preventing clinicians from implementing VOYAGER-PAD findings into everyday practice.

Dr. Rogers provides insight into...

10/30/2023

Vascular Disease Management

Review

06/08/2021

John N. Evans, DPM¹; Nicholas C. Claussen, BA²; Courtney S. Leslie, PharmD²; Kenneth T. Moore, MA, MS²

John N. Evans, DPM1; Nicholas C. Cla...

This review serves to introduce the most recent data with a factor Xa inhibitor as a novel antithrombotic strategy for PAD.

This review serves to introduce...

06/08/2021

July 18 ⁠–⁠ July 19

July 19 ⁠–⁠ July 20

July 24 ⁠–⁠ July 26

July 26 ⁠–⁠ July 27

July 27 ⁠–⁠ July 28

August 8 ⁠–⁠ August 9

August 14 ⁠–⁠ August 17

August 16 ⁠–⁠ August 18

August 16 ⁠–⁠ August 17